why choose us

First received: July 27, 2022

Clinical Trial: Nivolumab and All-trans Retinoic Acid for Pancreatic Cancer

Study Status: Completed

Recruit Status: Completed

Condition: Effect of Drug

Study Type: Interventional


Official Title: Treatment With Nivolumab and All-trans Retinoic Acid for Patients With Refractory Pancreatic Cancer

Brief Summary: This study is to examine the anticancer activity of the combination therapy with all-trans retinoic acid and nivolumab in patients with chemotherapy-refractory advanced or metastatic pancreatic adenocarcinoma.

Read more